BRAINSTORM CELL THERAPEUTICS INC. Public Float
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Public Float of $10.50 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $10.50M.
- 2024-06-30: Entity Public Float $25.55M.
- 2022-06-30: Entity Public Float $78.89M; Entity Public Float as first filed $92.96M.
- 2021-06-30: Entity Public Float $119.59M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $10.50M 10-K · filed 2026-03-31 | |
| 2024-06-30 | $25.55M 10-K · filed 2025-03-31 | |
| 2022-06-30 | $78.89M 10-K · filed 2024-04-01 | $92.96M 10-K · filed 2023-03-30 |
| 2021-06-30 | $119.59M 10-K · filed 2022-03-28 | |
| 2020-06-30 | $278.37M 10-K · filed 2021-02-04 | |
| 2019-06-30 | $75.37M 10-K · filed 2020-02-18 | |
| 2018-06-30 | $71.03M 10-K · filed 2019-04-01 | |
| 2017-06-30 | $67.67M 10-K · filed 2018-03-08 | |
| 2016-06-30 | $39.04M 10-K · filed 2017-03-29 | |
| 2015-06-30 | $57.97M 10-K · filed 2016-03-09 | |
| 2014-06-30 | $67.53M 10-K · filed 2015-03-26 | |
| 2013-06-30 | $25.01M 10-K · filed 2014-03-27 | |
| 2012-06-30 | $26.71M 10-K · filed 2013-03-14 | |
| 2011-06-30 | $43.40M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |